SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-061622
Filing Date
2024-05-17
Accepted
2024-05-17 16:05:17
Documents
1
Period of Report
2024-05-15

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5339
  Complete submission text file 0000950170-24-061622.txt   7114
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Issuer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Reporting) CIK: 0001957515 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38762 | Film No.: 24959535